A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice.

Suschak, John J; Golden, Joseph W; Fitzpatrick, Collin J; Shoemaker, Charles J; Badger, Catherine V; Schmaljohn, Connie S; Garrison, Aura R

Suschak, John J; Golden, Joseph W; Fitzpatrick, Collin J; Shoemaker, Charles J; Badger, Catherine V; Schmaljohn, Connie S; Garrison, Aura R.

Afiliação

Suschak JJ; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA. jjsuschak@gmail.com.
Golden JW; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.
Fitzpatrick CJ; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.
Shoemaker CJ; Diagnostics Systems Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.
Badger CV; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.
Schmaljohn CS; Headquarters Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.
Garrison AR; National Institute of Allergy and Infectious Diseases, Integrated Research Facility, Frederick, MD, USA.

NPJ Vaccines ; 6(1): 31, 2021 Mar 02.

Article em En | MEDLINE | ID: mdl-33654101

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google